Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
210.99Prev. Close
208.63Volume
1,47,288Total traded value
3.08 CrUpper Circuit
219.06Lower Circuit
198.19Fundamentals
| Market Cap | ₹4,753Cr |
| ROE | -146.15% |
| P/E Ratio(TTM) | -25.80 |
| EPS(TTM) | -8.10 |
| P/B Ratio | 20.39 |
| Dividend Yield | 0.00% |
| Industry P/E | 65.48 |
| Book Value | 10.25 |
| Debt to Equity | 0.00 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Suven Life Sciences
Suven Life Sciences is a biopharmaceutical company focused on discovering new molecules, known as New Chemical Entities, for treating complex Central Nervous System (CNS) disorders for 20 years. The company's core philosophy is 'Persistent Pursuit', reflecting a deep commitment to adapt and persevere through the significant challenges of innovating in highly demanding medical research areas. This dedication has cultivated a robust pipeline featuring 13 clinical and research assets that are being developed for multiple potential medical conditions.;
| Parent Organisation | Suven Life Sciences |
| Managing Director | NA |
| NSE Symbol | SUVEN |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Jul '25
Top Mutual Funds Invested(1)
| FUND NAME | AUM(%) |
|---|---|
| Quant Small Cap Fund Direct Plan Growth | 0.35% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| GMR Airports | NA (0.00%) | -424.81 | ||
| JSW Infrastructure | NA (0.00%) | 41.59 | ||
| Max Financial Services | NA (0.00%) | 205.40 | ||
| Aegis Vopak Terminals | NA (0.00%) | 210.04 |